statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	857
IT - Italia	289
SG - Singapore	288
CN - Cina	202
VN - Vietnam	157
HK - Hong Kong	115
DE - Germania	103
RU - Federazione Russa	102
BR - Brasile	94
GB - Regno Unito	59
IN - India	59
KR - Corea	48
FR - Francia	35
ID - Indonesia	29
JP - Giappone	29
FI - Finlandia	22
AU - Australia	21
CA - Canada	21
MY - Malesia	20
ES - Italia	19
IE - Irlanda	19
NL - Olanda	19
PK - Pakistan	16
BD - Bangladesh	15
IR - Iran	15
TR - Turchia	15
BE - Belgio	14
IQ - Iraq	14
MX - Messico	14
PL - Polonia	14
DK - Danimarca	11
ZA - Sudafrica	11
AR - Argentina	9
PH - Filippine	6
TW - Taiwan	6
UZ - Uzbekistan	6
CO - Colombia	5
EC - Ecuador	5
NO - Norvegia	5
SE - Svezia	5
TN - Tunisia	5
AT - Austria	4
EG - Egitto	4
NP - Nepal	4
UA - Ucraina	4
VE - Venezuela	4
BY - Bielorussia	3
CL - Cile	3
CR - Costa Rica	3
IL - Israele	3
LT - Lituania	3
MA - Marocco	3
PT - Portogallo	3
SA - Arabia Saudita	3
AE - Emirati Arabi Uniti	2
AZ - Azerbaigian	2
GR - Grecia	2
HU - Ungheria	2
JO - Giordania	2
LB - Libano	2
NZ - Nuova Zelanda	2
PY - Paraguay	2
AL - Albania	1
AM - Armenia	1
BB - Barbados	1
BJ - Benin	1
CH - Svizzera	1
ET - Etiopia	1
GH - Ghana	1
KE - Kenya	1
KG - Kirghizistan	1
KH - Cambogia	1
KZ - Kazakistan	1
MK - Macedonia	1
MO - Macao, regione amministrativa speciale della Cina	1
MT - Malta	1
MU - Mauritius	1
NG - Nigeria	1
NI - Nicaragua	1
PE - Perù	1
SI - Slovenia	1
TH - Thailandia	1
UY - Uruguay	1
Totale	2.879

Nome	#
Developing New Anti-Tuberculosis Vaccines: Focus on Adjuvants	437
Development of New Toll-Like Receptor 4-directed adjuvants and Clarification of their Mechanism of Action	435
Vibrational spectroscopy coupled with machine learning sheds light on the cellular effects induced by rationally designed TLR4 agonists	332
New Glucosamine-Based TLR4 Agonists: Design, Synthesis, Mechanism of Action, and In Vivo Activity as Vaccine Adjuvants	285
Study on the impact of Toll-like Receptor 4 (TLR4) modulation in rare inflammatory-fibrotic diseases	281
Novel TLR4-Activating Vaccine Adjuvant Enhances the Production of Enterococcus faecium-binding Antibodies	236
Towards more efficient synthetic immunomodulators: biological characterization and mechanism of action of monosaccharide-derived TLR4 agonists	232
Overcoming Challenges in Chemical Glycosylation to Achieve Innovative Vaccine Adjuvants Possessing Enhanced TLR4 Activity	221
A Global Picture of Molecular Changes Associated to LPS Treatment in THP-1 Derived Human Macrophages by Fourier Transform Infrared Microspectroscopy	212
Use of Fluorescent Chemical Probes in the Study of Toll-like Receptors (TLRs) Trafficking	154
Study on the impact of Toll-like Receptor 4 (TLR4) modulation in rare inflammatory-fibrotic diseases	103
Totale	2.928

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	28	0	0	0	0	0	0	0	0	0	0	12	16
2021/2022	115	15	9	9	11	10	7	7	8	5	8	9	17
2022/2023	124	17	16	10	10	14	9	2	6	5	21	8	6
2023/2024	260	1	6	18	13	13	16	21	38	36	35	26	37
2024/2025	892	43	49	76	48	70	54	46	42	70	118	80	196
2025/2026	1.459	195	97	125	214	175	78	225	56	111	159	24	0
Totale													2.928

Bicocca Open Archive